InvestorsHub Logo
Followers 75
Posts 4648
Boards Moderated 0
Alias Born 09/06/2003

Re: DewDiligence post# 6400

Monday, 03/04/2024 11:29:29 AM

Monday, March 04, 2024 11:29:29 AM

Post# of 7239

RVNC is not going to spend money on a migraine trial anytime soon (if ever).



Per Revance’s charts (I’ve not tried to verify it) migraine is the biggest therapeutic indication. By far (per charts: CD is 14%, ULS is 27%, Migraine is 40%). It makes sense for them to spend money to make it easy for injectors to switch to it - especially after their experience with the esthetic injectors being unwilling or incapable of developing their own protocols.

Whether this means full approval, or just running a really clean ph2, or sponsoring several Independent Investigator trials … I don’t know. But it’s almost certainly very worthwhile for them to spend $ ASAP to get access to this market.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News